SCHEMBL7478034

SCHEMBL7478034

FC(F)(F)c1csc(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
HIF1A Q16665 1/20 0.38
TXNRD1 Q16881 1/20 0.38
TXNRD3 Q86VQ6 1/20 0.38
TXNRD2 Q9NNW7 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
DAO P14920 1/20 0.37
ALOX5 P09917 1/20 0.35
CES2 O00748 1/20 0.34
TRPA1 O75762 1/20 0.34
GPR35 Q9HC97 2/20 0.33
PTPN5 P54829 3/20 0.32
AHR P35869 1/20 0.32
IDO1 P14902 1/20 0.31
RAPGEF4 Q8WZA2 1/20 0.31
PDE2A O00408 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24917503 0.74 DAO (0.47) DAOCES2TRPA1GPR35
SCHEMBL421763 0.72 GABRB3 (0.42) ALDH1A1TSHRCYP3A4HPGDALOX15
SCHEMBL28138980 0.72 TSHR (0.39) ALDH1A1TSHRHPGDPTPN5IDO1
SCHEMBL16467657 0.72 MPL (0.34) ALDH1A1TSHRCES2PTPN5
Hydrochloric Acid SCHEMBL4712893 0.70 PTPN5 (0.41) ALDH1A1TSHRHPGDPTPN5IDO1
SCHEMBL127047 0.70 DAO (0.37) ALDH1A1TSHRDAOCES2PTPN5
SCHEMBL28159091 0.70 PTPN5 (0.31) ALDH1A1TSHRCES2PTPN5
SCHEMBL10979818 0.70 KIF11 (0.36) HPGD
SCHEMBL16369693 0.70
SCHEMBL1042850 0.69 ALDH1A1 (0.45) ALDH1A1TSHRCYP3A4HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1194417-A1 PHENOXY FLUOROPYRIMIDINES BAYER AG (DE) 2002-04-10 EP claimed
WO-2000078733-A1 PHENOXY FLUOROPYRIMIDINES BAYER AKTIENGESELLSCHAFT (DE) 2000-12-28 WO claimed
US-20230348453-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2023-11-02 US disclosed
CN-115667255-A Halogenated heteroaryl and other heterocyclic kinase inhibitors and uses thereof 艾欧麦克斯治疗股份公司 2023-01-31 CN disclosed
EP-1194417-A1 PHENOXY FLUOROPYRIMIDINES BAYER AG (DE) 2002-04-10 EP disclosed
WO-2000078733-A1 PHENOXY FLUOROPYRIMIDINES BAYER AKTIENGESELLSCHAFT (DE) 2000-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348453-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF ABL1, PRKDC, PRKACA ALDH1A1 2606/4885TSHR 2835/4885CYP3A4 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.